Investor Relations

Esperion Therapeutics, Inc. is a pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of hypercholesterolemia.

Esperion Therapeutics is a publicly traded company (since 2013) and is listed on the NASDAQ Global Select Market under the symbol ESPR.

Esperion Therapeutics (NASDAQ: ESPR) 1:00 PM ET on Nov 27, 2015
Last Price Change Open Day High 52-Week High
0.39  up   (1.383%) 28.45 29.24 120.96
Volume Previous Close Day Low 52-Week Low
173,700 28.20 28.21 18.07

View all »   RSSRecent Releases

Nov 6, 2015
Esperion Therapeutics to Present at November Healthcare Conferences

Nov 5, 2015
Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Third Quarter 2015 Financial Results